| Bioactivity | Olacaftor (VX-440) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408. | |||||||||
| Target | CFTR | |||||||||
| Name | Olacaftor | |||||||||
| CAS | 1897384-89-2 | |||||||||
| Formula | C29H34FN3O4S | |||||||||
| Molar Mass | 539.66 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Miller M, et al. Modulators of cystic fibrosis transmembrane conductance regulator. US9782408. |
Olacaftor
CAS: 1897384-89-2 F: C29H34FN3O4S W: 539.66
Olacaftor (VX-440) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US978
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.